Fairman Group’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$517 Hold
5
﹤0.01% 314
2026
Q1
$359 Hold
5
﹤0.01% 309
2025
Q4
$397 Hold
5
﹤0.01% 316
2025
Q3
$377 Hold
5
﹤0.01% 258
2025
Q2
$345 Hold
5
﹤0.01% 239
2025
Q1
$224 Hold
5
﹤0.01% 244
2024
Q4
$224 Hold
5
﹤0.01% 330
2024
Q3
$314 Hold
5
﹤0.01% 369
2024
Q2
$295 Hold
5
﹤0.01% 369
2024
Q1
$399 Hold
5
﹤0.01% 354
2023
Q4
$395 Buy
+5
New +$356 ﹤0.01% 354

Other funds holding CVS

Fairman Group's CVS Position: Q2 2026 in Review

Fairman Group held its CVS Health (CVS) position steady in Q2 2026 at 5 shares worth $517. The position accounts for ﹤0.01% of the portfolio, ranked #314.

Fairman Group first reported a position in CVS in Q4 2023 and has held it in 11 quarters since. 2,069 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Fairman Group held 5 shares of CVS Health worth $517 as of Q2 2026.
  • Fairman Group left its CVS Health share count unchanged in Q2 2026.
  • CVS Health made up ﹤0.01% of Fairman Group's portfolio in Q2 2026, its #314 holding.
  • Fairman Group first reported a position in CVS Health in Q4 2023 and has held it in 11 quarters since.
  • 2,069 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Fairman Group's 13F filing for Q2 2026, filed 4 Aug 2026.